Detalhe da pesquisa
1.
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
N Engl J Med
; 385(27): 2531-2543, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965338
2.
Disclosure to South African children about their own HIV status over time.
AIDS Care
; 35(3): 334-340, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930060
3.
Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence.
BMC Public Health
; 22(1): 1312, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804333
4.
Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071055
5.
Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral Therapy.
J Pediatr
; 227: 308-313.e2, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712285
6.
Educational delays among children living with perinatally-acquired HIV in Johannesburg, South Africa.
AIDS Care
; 32(4): 438-444, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31288549
7.
Recovery of HIV encephalopathy in perinatally infected children on antiretroviral therapy.
Dev Med Child Neurol
; 62(11): 1309-1316, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779195
8.
Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status.
AIDS Care
; 29(3): 378-386, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27569657
9.
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.
Lancet
; 382(9904): 1555-63, 2013 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24209829
10.
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.
Lancet HIV
; 11(5): e300-e308, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621393
11.
Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa.
AIDS
; 37(10): 1583-1591, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199568
12.
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
EClinicalMedicine
; 60: 102025, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37304494
13.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Lancet Child Adolesc Health
; 7(10): 718-727, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562418
14.
Experiences of South African caregivers disclosing to their children living with HIV: Qualitative investigations.
PLoS One
; 17(11): e0277202, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445899
15.
Impact of Disclosure over Time on the Emotional Well-Being of Children with Perinatally Acquired HIV Infection in South Africa.
J Dev Behav Pediatr
; 43(3): e188-e196, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570068
16.
Children's Positive and Negative Emotional Responses to an HIV Disclosure Study in South Africa.
Front Pediatr
; 10: 857336, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35712628
17.
Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS.
PLoS One
; 17(10): e0276116, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240212
18.
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
Lancet HIV
; 9(9): e638-e648, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055295
19.
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial.
Lancet Child Adolesc Health
; 5(9): 642-651, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302760
20.
The Etiology of Pneumonia in HIV-1-infected South African Children in the Era of Antiretroviral Treatment: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study.
Pediatr Infect Dis J
; 40(9S): S69-S78, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448746